ReviewCurrent genomics2025
Decoding the Methylome: Insights into the Epigenetic Regulation of Polycystic Ovarian Syndrome through Mitochondrial DNA Methylation.
Review in Current genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polycystic Ovarian Syndrome (PCOS) imposes significant societal health and economic challenges. The precise determinants behind the global prevalence of PCOS are still poorly understood. However, epigenetic modifications in PCOS, such as DNA methylation, have been recognized as a method by which the environment interacts with the genome. Evidence suggests that changes in mitochondrial (mt)DNA methylation may have a role in the heightened occurrence of PCOS. This article provides a comprehensive overview of nuclear DNA methylation, mitochondrial DNA methylation, and their significance in regulating gene expression. Pre-existing scholarly works shed insight into the complex interaction of DNA methylation and other epigenetic modifications associated with PCOS. In addition, this review gathers a detailed explanation of several methodologies employed to assess alterations in DNA methylation at specific sites and across the nuclear and mitochondrial genomes. Integrating mtDNA methylation alterations may be a promising diagnostic strategy for PCOS, potentially paving the way for novel therapeutic interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.